Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.855 USD | -6.09% | -17.49% | -11.06% |
Mar. 18 | Allogene Therapeutics, Inc.(NasdaqGS:ALLO) added to S&P Biotechnology Select Industry Index | CI |
Mar. 15 | Allogene Therapeutics Files $500 Million Mixed Shelf | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.06% | 519M | |
-2.26% | 104B | |
+1.41% | 97.42B | |
+0.79% | 22.2B | |
-17.84% | 21.23B | |
-11.11% | 18.33B | |
-42.83% | 16.35B | |
-17.63% | 15.06B | |
+4.55% | 13.98B | |
+32.11% | 11.66B |
- Stock Market
- Equities
- ALLO Stock
- News Allogene Therapeutics, Inc.
- Oppenheimer Adjusts Allogene Therapeutics Price Target to $35 From $40, Maintains Outperform Rating